Yemaachi Biotech · Jul 2026
Describes Yemaachi’s AACR 2026 presence, including a CEO-chaired session on multi-omic technologies and the role of TACA in expanding African representation in cancer research.
Diversifying precision cancer diagnostics and treatments
Public company, workplace, funding, and market signals
Ghana-based biotech company focused on precision oncology in African populations, building the Yemaachi Cancer Knowledge Base / African Cancer Atlas and offering diagnostic and sequencing services.
Primary product
The African Cancer Atlas (TACA) / Yemaachi Cancer Knowledge Base
Founded
2020
Headquarters
1 Round House Road, Abelempke, Accra, Ghana
Team size
11-50 employees
Work style
Onsite
Industry
Biotechnology Research
Sub-industry
Precision oncology / cancer genomics
Offices
0 jobs at Yemaachi Biotechnology
Check back later for new openings
Business model
Stage
seed
Total raised
$29.4M
Latest round
Grant · Mar 2024
Latest amount
$25M
Leadership
Co-Founder & CEO
Co-Founder & CTO
Co-Founder / Head of Technical Services
Co-Founder & CFO / CBO
Director, Operations & Regulatory Affairs
Vice President, Strategic Partnerships
Director of Clinical Affairs
Director - Commercial Projects / Country Director - Kenya
Head of Genetics
Representative, Francophone Africa / Molecular Epidemiology
Abdoulaye Diallo
Bioinformatics & Machine Learning
Investors
Mission-driven and people-first, with official values emphasizing respect, empowerment, excellence, inclusivity, trust, and putting people ahead of profit.
Work style
Onsite
Benefits
Pricing
Not publicly disclosed; services appear to be a mix of partner-led research, grants, and paid sequencing/diagnostic services.
Differentiators
Technology
Customers
Competitors
Estimated revenue
$1M-$10M
Estimated monthly visits
3.5K
Traffic estimate as of Jun 2026
Yemaachi Biotech · Jul 2026
Describes Yemaachi’s AACR 2026 presence, including a CEO-chaired session on multi-omic technologies and the role of TACA in expanding African representation in cancer research.
Yemaachi Biotech · May 2026
Reports early TACA implementation across five countries, 236 recruited participants, and operational challenges such as IRB timelines, biospecimen transport, and FFPE quality.
GenomeWeb · Apr 2026
External coverage of AACR-related work and TACA, including recruitment across multiple countries and the broader precision-medicine significance of African ancestry genomics.
Forbes Africa · Feb 2026
Profiles Yaw Bediako and the company’s progress, including the African Cancer Atlas, scale-up plans, and the company’s next fundraising ambitions.
Yemaachi Biotech · Feb 2025
Launches TACA with Roche as founding/anchor partner; aims to generate genomic and clinical data from up to 7,500 African cancer patients (15,000 genomes) and make the database free for African-based researchers.